Evidence map›Paper›PMID 22114776›Full record

ArticleExpert review of clinical pharmacology2011

Clinical pharmacology at the core of translational science.

Scott A Waldman, Andre Terzic

Abstract readEditorial
In one paragraph

Article in Expert review of clinical pharmacology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Systems approaches evolve clinical pharmacology.CPT: pharmacometrics & systems pharmacology · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Scott A Waldman
Andre Terzic

Funding

X-Ray Crystallography and Macromolecular CharacterizationP30CA056036 · NCI · THOMAS JEFFERSON UNIVERSITY · PI DANIEL P SILVER · 1995 to 2026
$94.8M
Guanylyl Cyclase C in Blood and Colorectal CancerR01CA095026 · NCI · THOMAS JEFFERSON UNIVERSITY · PI WALDMAN, SCOTT A · 2003 to 2008
$5.1M
Occult lymph node metastases and racial disparities in colon cancer outcomesRC1CA146033 · NCI · THOMAS JEFFERSON UNIVERSITY · PI WALDMAN, SCOTT A · 2009 to 2010
$997k
Nonlinear Models of mRNA Expression in Cancer by RT-PCRR33CA112147 · NCI · THOMAS JEFFERSON UNIVERSITY · PI HYSLOP, TERRY · 2007 to 2009
$666k
Nonlinear Models of mRNA Expression in Cancer by RT-PCRR21CA112147 · NCI · THOMAS JEFFERSON UNIVERSITY · PI HYSLOP, TERRY · 2005 to 2005
$140k
NCI NIH HHS CA112147NCI NIH HHS CA146033NCI NIH HHS CA56036NCI NIH HHS CA95026NCI NIH HHS P30 CA056036NCI NIH HHS R01 CA095026NCI NIH HHS R21 CA112147NCI NIH HHS R33 CA112147NCI NIH HHS RC1 CA146033
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsHumansNational Institutes of Health (U.S.)Pharmacology, ClinicalTranslational Research, BiomedicalUnited States

Identifiers

PMID22114776
PMCPMC7003533

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.